Stellantis Considers Closing, Selling Brampton Assembly Plant
Automaker Stellantis told union Unifor it is seriously considering closing and selling its idled Brampton, Ontario assembly plant, putting approximately 3,000 auto jobs at risk and raising questions about the company's commitment to Canadian manufacturing.
On August 12, 2026, Stellantis notified Unifor that it is seriously considering the closure and sale of its Brampton Assembly Plant, which has been idle since December 2023. The plant was initially shut down to retool for production of the Jeep Compass electric SUV, but the company paused that work in early 2025 before announcing in October 2025 that Compass production would relocate to the United States.
Impact on Workers and Community
- Approximately 3,000 auto workers and more than 2,200 Unifor Local 1285 members could be affected
- The Brampton plant has been an economic anchor for the community for generations
- Unifor argues the relocation violates both the collective agreement and agreements made with government for significant federal and provincial funding
Unifor National President Lana Payne called the potential closure a "lose-lose scenario" and said the union will raise the issue during upcoming contract negotiations with Stellantis and other automakers. The union is calling on the federal government to implement policies that would protect Canada's auto manufacturing sector.
For foreigners considering work in Canada's automotive sector or looking to settle in the Greater Toronto Area, this development signals ongoing challenges in manufacturing employment stability. The sector remains vulnerable to tariff pressures and shifting production strategies by multinational corporations, which could affect long-term job security for skilled tradespeople.
Sources
MyHAbroad is an independent app and is not affiliated with, endorsed by, or representing any government or public authority. This is general information only — not legal, tax, medical, or financial advice. Always verify with the official source before acting:
